SEC Form 4 · accession 0000905718-18-000016
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis M Brown
Officer — Chief Scientific Officer · Director
Period of report
Dec 13, 2017
Accepted (ET)
Jan 3, 2018 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 13, 2017 | G | 129,600 | $0.00 | D | 218,246 | D | |
| Common StockF2 | Dec 31, 2017 | J | 169 | $3.20 | A | 218,415 | D | |
| Common StockF3 | holding | — | — | — | 537,500 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involved a gift of securities by the Reporting Person to his adult children, and an adult custodian of family members. This disposition was made for estate planning purposes.
- F2The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- F3Held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares.